Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;141(1):36-42.
doi: 10.1016/j.ygyno.2016.02.028.

New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome

Affiliations

New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome

Andres A Roma et al. Gynecol Oncol. 2016 Apr.

Abstract

We present a recently introduced three tier pattern-based histopathologic system to stratify endocervical adenocarcinoma (EAC) that better correlates with lymph node (LN) metastases than FIGO staging alone, and has the advantage of safely predicting node-negative disease in a large proportion of EAC patients. The system consists of stratifying EAC into one of three patterns: pattern A tumors characterized by well-demarcated glands frequently forming clusters or groups with relative lobular architecture and lacking destructive stromal invasion or lymphovascular invasion (LVI), pattern B tumors demonstrating localized destructive invasion (small clusters or individual tumor cells within desmoplastic stroma often arising from pattern A glands), and pattern C tumors with diffusely infiltrative glands and associated desmoplastic response. Three hundred and fifty-two cases were included; mean follow-up 52.8 months. Seventy-three patients (21%) had pattern A tumors; all were stage I and there were no LN metastases or recurrences. Pattern B was seen in 90 tumors (26%); all were stage I and LVI was seen in 24 cases (26.6%). Nodal disease was found in only 4 (4.4%) pattern B tumors (one IA2, two IB1, one IB not further specified (NOS)), each of which showed LVI. Pattern C was found in 189 cases (54%), 117 had LVI (61.9%) and 17% were stage II or greater. Forty-five (23.8%) patients showed LN metastases (one IA1, 14 IB1, 5 IB2, 5 IB NOS, 11 II, 5 III and 4 IV) and recurrences were recorded in 41 (21.7%) patients. This new risk stratification system identifies a subset of stage I patients with essentially no risk of nodal disease, suggesting that patients with pattern A tumors can be spared lymphadenectomy. Patients with pattern B tumors rarely present with LN metastases, and sentinel LN examination could potentially identify these patients. Surgical treatment with nodal resection is justified in patients with pattern C tumors.

Keywords: Classification system; Endocervical adenocarcinoma; Invasive carcinoma; Lymph node metastasis; Pattern-based; Risk stratification.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest or funding to disclose.

Figures

Figure 1
Figure 1
Figure 1A: Deeply invasive well differentiated endocervical adenocarcinoma corresponding to pattern A tumor. H&E 40X. B: Low power examination of exophytic and invasive endocervical adenocarcinoma also corresponding to pattern A tumor. Higher examination is recommended to rule out questionable pattern B areas (arrows). H&E 40X. C–E: High power examination of invasive endocervical adenocarcinoma composed of glands with irregular contours (arrows) in a focally desmoplastic stroma arising from pattern A type glands. H&E 200X. F: Pattern C composed of diffuse destructive invasion, irregular and incomplete glands, some with cribriform architecture in a diffuse desmoplastic stroma. H&E40X.

References

    1. Diaz De Vivar A, Roma AA, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, et al. Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol. 2013;32:592–601. - PubMed
    1. Roma AA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, et al. Invasive Endocervical Adenocarcinoma: A New Pattern-based Classification System With Important Clinical Significance. Am J Surg Pathol. 2015;39:667–72. - PubMed
    1. Paquette C, Jeffus SK, Quick CM, Conaway MR, Stoler MH, Atkins KA. Interobserver variability in the application of a proposed histologic subclassification of endocervical adenocarcinoma. Am J Surg Pathol. 2015;39:93–100. - PubMed
    1. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–104. - PubMed
    1. Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116:140–6. - PubMed

Publication types